DrugPatentWatch Database Preview
Drugs in Development Information for Nepadutant
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Nepadutant?
Nepadutant is an investigational drug.
There have been 4 clinical trials for Nepadutant.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Colic, Gastrointestinal Diseases, and Digestive System Diseases. The leading clinical trial sponsors are Menarini Group and [disabled in preview].
There are five US patents protecting this investigational drug and two hundred and one international patents.
Summary for Nepadutant
| US Patents | 5 |
| International Patents | 201 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2010-11-01) |
| Vendors | 0 |
Recent Clinical Trials for Nepadutant
| Title | Sponsor | Phase |
|---|---|---|
| Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance | Menarini Group | Phase 2 |
| Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment | Menarini Group | Phase 2 |
| Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic | Menarini Group | Phase 2 |
Clinical Trial Summary for Nepadutant
Top disease conditions for Nepadutant
Top clinical trial sponsors for Nepadutant
US Patents for Nepadutant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Nepadutant | Start Trial | Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists | Boehringer Ingelheim Pharma KG (Ingelheim, DE) | Start Trial |
| Nepadutant | Start Trial | Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists | Boehringer Ingelheim Pharma KG (Ingelheim, DE) | Start Trial |
| Nepadutant | Start Trial | Pharmaceutical aerosol composition | Pari GmbH (Starnberg, DE) | Start Trial |
| Nepadutant | Start Trial | Surface topographies for non-toxic bioadhesion control | University of Florida Research Foundation, Inc. (Gainesville, FL) | Start Trial |
| Nepadutant | Start Trial | Pediatric oral liquid compositions containing nepadutant | LABORATORI GUIDOTTI S.P.A. (Pisa, IT) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Nepadutant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Nepadutant | Argentina | 034213 | 2021-03-07 | Start Trial |
| Nepadutant | Argentina | 038494 | 2021-03-07 | Start Trial |
| Nepadutant | Argentina | 038765 | 2020-10-31 | Start Trial |
| Nepadutant | Austria | 430581 | 2020-10-31 | Start Trial |
| Nepadutant | Austria | 444067 | 2020-10-31 | Start Trial |
| Nepadutant | Austria | 452639 | 2020-10-31 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
